Brand PerformancePOWERED BY
Main logo&Moja gazetka logo
Brand Performance logo

The brand Metafen belongs to the Painkillers and anti-inflammatory drugs category.

Metafen holds a 0.68% market share in the Painkillers and anti-inflammatory drugs category.

FMCG brand market share data from Polish consumer shopping lists, sourced from Listonic and Moja Gazetka and updated weekly.

Metafen

Painkillers and anti-inflammatory drugs
to receive information about changes in the popularity of this brand.
BRAND CHARTS
Udział procentowy marek w kategorii Painkillers and anti-inflammatory drugs
MarkaUdział procentowy
Ibuprom31.60%
Ibuprofen13.24%
Apap12.35%
Paracetamol11.82%
Ibum6.62%
Nurofen6.52%
Pyralgina3.74%
Voltaren2.87%
Ketonal2.55%
Polopiryna2.17%
Ibufen1.17%
Opokan0.96%
Metafen0.68%
Naproxen0.64%
Aspirin0.49%
Etopiryna0.46%
Olfen0.34%
Panadol0.32%
Excedrin0.31%
Efferalgan0.31%
Nomigren0.28%
Traumon0.27%
Reparil0.13%
Kidofen Duo0.08%
Aleve0.05%
Moilec0.02%
Kopiryna0.00%

Brand Metafen percentage share in the category Painkillers and anti-inflammatory drugs in the last month

Show data up to:
The chart shows data for the 4 weeks leading up to the selected date. The information is updated every Monday and includes data up to Sunday.
0.68%Metafen
ALL BRANDS
Historyczny udział procentowy marek w kategorii Painkillers and anti-inflammatory drugs (miesięcznie)
MiesiącParacetamolPyralginaIbupromPolopirynaNurofenMetafenPanadolIbufenApapIbumAspirinIbuprofenEtopirynaAleveEfferalganExcedrinKetonalKidofen DuoKopirynaNaproxenOlfenOpokanNomigrenVoltarenMoilecTraumonReparil
2024-09-01T00:00:0011.20%3.51%30.24%3.32%7.78%0.84%0.35%1.37%12.08%7.19%0.74%11.45%0.38%0.17%0.35%0.56%2.86%0.15%0.00%0.88%0.45%0.98%0.24%2.51%0.04%0.32%0.04%
2024-10-01T00:00:0010.13%3.85%30.85%3.78%7.57%0.79%0.39%1.41%12.11%7.66%0.75%11.36%0.37%0.13%0.39%0.45%2.61%0.12%0.01%0.70%0.49%0.84%0.10%2.61%0.06%0.28%0.15%
2024-11-01T00:00:0010.80%3.71%31.29%3.30%8.24%1.27%0.41%1.50%11.58%7.45%0.79%10.24%0.30%0.17%0.47%0.48%2.56%0.27%0.03%0.64%0.50%0.82%0.08%2.53%0.06%0.44%0.06%
2024-12-01T00:00:0011.20%3.48%30.16%3.25%8.97%0.68%0.34%1.61%12.30%7.68%0.85%11.58%0.51%0.15%0.31%0.36%1.83%0.13%0.01%0.58%0.42%1.11%0.19%1.91%0.06%0.22%0.12%
2025-01-01T00:00:0012.40%3.55%27.94%3.58%8.34%0.68%0.28%1.65%12.32%8.33%0.95%10.92%0.43%0.25%0.36%0.29%2.08%0.28%0.02%0.81%0.52%0.98%0.16%2.16%0.06%0.53%0.13%
2025-02-01T00:00:0011.30%3.45%28.97%3.55%8.85%0.83%0.48%1.81%11.93%7.79%0.82%11.36%0.44%0.16%0.46%0.31%2.48%0.21%0.01%0.57%0.46%0.68%0.18%2.33%0.05%0.42%0.12%
2025-03-01T00:00:0011.17%3.18%29.94%2.88%8.40%0.82%0.35%1.65%12.31%7.13%0.67%12.41%0.52%0.29%0.27%0.26%2.52%0.13%0.00%0.80%0.46%0.77%0.22%2.23%0.06%0.48%0.09%
2025-04-01T00:00:0010.97%3.58%30.96%2.52%7.21%0.76%0.35%1.57%12.38%7.38%0.55%11.64%0.44%0.09%0.21%0.49%2.68%0.15%0.03%0.95%0.58%1.02%0.26%2.58%0.11%0.41%0.12%
2025-05-01T00:00:0011.17%3.42%30.07%2.02%7.34%0.78%0.41%1.08%12.46%7.34%0.45%12.13%0.48%0.40%0.29%0.46%2.75%0.24%0.03%0.57%0.57%1.37%0.13%3.42%0.05%0.46%0.13%
2025-06-01T00:00:0012.04%3.22%31.14%1.34%7.99%0.71%0.38%1.53%12.47%7.57%0.29%11.35%0.45%0.27%0.35%0.38%2.36%0.08%0.05%0.82%0.42%0.98%0.21%2.83%0.06%0.48%0.24%
2025-07-01T00:00:0010.37%3.22%32.07%1.15%8.08%0.79%0.48%1.34%12.65%7.82%0.26%11.81%0.60%0.23%0.32%0.33%2.55%0.12%0.03%0.74%0.61%1.05%0.13%2.58%0.07%0.51%0.10%
2025-08-01T00:00:0010.89%3.48%30.55%1.43%7.73%0.71%0.33%1.40%13.32%6.81%0.59%11.62%0.69%0.27%0.22%0.32%3.01%0.10%0.03%0.81%0.68%1.21%0.23%2.86%0.06%0.48%0.16%
2025-09-01T00:00:0012.31%3.30%29.97%2.57%7.28%0.73%0.37%1.34%11.97%6.87%0.73%12.79%0.24%0.49%0.34%0.40%2.79%0.15%0.03%0.79%0.34%1.11%0.21%2.42%0.02%0.35%0.09%
2025-10-01T00:00:0011.51%3.58%31.02%3.77%7.54%0.87%0.46%0.91%11.70%6.44%0.79%12.02%0.35%0.29%0.51%0.24%2.24%0.06%0.00%1.08%0.59%0.94%0.16%2.46%0.06%0.38%0.03%
2025-11-01T00:00:0010.37%3.34%30.24%3.12%7.92%0.97%0.22%1.25%12.48%6.63%0.68%12.49%0.36%0.37%0.44%0.20%2.80%0.05%0.05%0.73%0.70%1.24%0.22%2.61%0.03%0.36%0.14%
2025-12-01T00:00:0011.48%3.51%30.77%2.91%8.84%0.79%0.23%1.49%11.43%8.13%0.72%11.45%0.49%0.14%0.48%0.27%2.12%0.15%0.01%0.75%0.54%0.73%0.28%1.91%0.04%0.23%0.07%
2026-01-01T00:00:0013.17%4.11%28.82%2.67%8.06%0.69%0.32%1.20%11.68%6.96%0.70%12.82%0.36%0.06%0.30%0.32%2.05%0.10%0.02%0.70%0.52%0.92%0.14%2.60%0.05%0.46%0.20%
2026-02-01T00:00:0012.58%3.58%28.81%3.32%8.19%0.84%0.41%1.92%11.80%7.03%0.66%12.01%0.38%0.03%0.34%0.49%1.99%0.21%0.01%0.77%0.55%0.94%0.22%2.55%0.00%0.29%0.10%
2026-03-01T00:00:0012.53%3.57%30.19%2.38%6.99%0.82%0.45%1.30%11.90%6.78%0.66%12.34%0.40%0.12%0.24%0.45%2.72%0.16%0.05%0.64%0.43%1.39%0.23%2.69%0.00%0.49%0.07%
2026-04-01T00:00:0011.38%3.78%30.16%2.65%7.36%0.92%0.32%1.48%12.22%6.78%0.48%12.57%0.60%0.08%0.24%0.39%2.10%0.19%0.00%0.81%0.60%1.10%0.26%2.94%0.05%0.40%0.16%
2026-05-01T00:00:0011.57%3.83%30.34%1.73%7.30%0.59%0.44%1.32%12.46%6.48%0.41%13.04%0.50%0.04%0.25%0.34%2.83%0.09%0.02%0.93%0.68%1.28%0.18%2.92%0.04%0.36%0.09%
2026-06-01T00:00:0012.44%3.19%31.79%1.19%7.28%0.69%0.23%1.45%12.35%6.99%0.41%13.01%0.48%0.06%0.29%0.30%2.41%0.14%0.00%0.77%0.48%1.07%0.22%2.40%0.05%0.26%0.06%
2026-07-01T00:00:0012.00%3.54%30.20%1.01%7.96%0.63%0.38%1.34%12.36%7.33%0.41%12.37%0.33%0.11%0.35%0.35%2.63%0.11%0.02%0.81%0.43%1.53%0.30%2.81%0.07%0.49%0.13%
2026-08-01T00:00:0012.01%3.91%29.56%1.31%7.04%0.75%0.23%1.15%12.89%7.56%0.31%12.65%0.66%0.15%0.21%0.29%2.53%0.04%0.03%0.82%0.56%1.30%0.49%3.03%0.01%0.46%0.06%

Percentage share of tagged brands in individual months

How the share of the selected brands in the Painkillers and anti-inflammatory drugs category has changed over the months
The method of counting additions changed in June 2026 – comparisons with periods before that date may not be fully reliable.
Show data up to:
Range:
Metafen
Others
Ibuprom
Ibuprofen
Apap
Paracetamol
Ibum
Nurofen
Pyralgina
Voltaren
Ketonal
Polopiryna
Ibufen
Opokan
Naproxen
Aspirin
Etopiryna
Olfen
Panadol
Excedrin
Efferalgan
Nomigren
Traumon
Reparil
Kidofen Duo
Aleve
Moilec
Kopiryna

Sources of additions to shopping lists

Shows the monthly share of sources from which users added products of the brand Metafen from the Painkillers and anti-inflammatory drugs category to shopping lists.
The method of counting additions changed in June 2026 – comparisons with periods before that date may not be fully reliable.
Show data up to:
Range:
Manual entry (organic)
Leaflets
Advertising
SUBCATEGORY CHARTS

Time to store

Shows how much time passes from adding a product from a given subcategory to a shopping list to the moment of purchase
76.5 h
Painkillers and anti-inflammatory drugs
Type Planned | Over 72 h
Products added well in advance and purchased during planned, less frequent shopping trips. The long time from list to purchase reflects a deliberate, cyclical decision.
Comparison with the other subcategories in “Health”
Condoms
Contact lenses
Heartburn medicines
Painkillers and anti-inflammatory drugs
Allergy medicines
Cold and runny nose medicines
Digestive medicines
54.8 h
69 h
73.1 h
76.5 h
78 h
85.9 h
86.6 h
Median of the Health category: 86.6 h
Medicines for herpes and skin problems
Dietary supplements and vitamins for adults
Antispasmodics
Dietary supplements and vitamins for children
Potency and libido medicines
Fertility drugs
99.2 h
103.6 h
125 h
135.6 h
287.7 h
783.6 h
Brand Loyalty Index (BLI) marki w kategorii Painkillers and anti-inflammatory drugs (miesięcznie)
MiesiącBLI (%)
2024-09-01T00:00:0084.01%
2024-10-01T00:00:0082.57%
2024-11-01T00:00:0084.63%
2024-12-01T00:00:0084.93%
2025-01-01T00:00:0087.33%
2025-02-01T00:00:0086.70%
2025-03-01T00:00:0083.54%
2025-04-01T00:00:0084.52%
2025-05-01T00:00:0082.11%
2025-06-01T00:00:0082.58%
2025-07-01T00:00:0080.67%
2025-08-01T00:00:0081.59%
2025-09-01T00:00:0080.29%
2025-10-01T00:00:0084.19%
2025-11-01T00:00:0086.83%
2025-12-01T00:00:0094.64%
2026-01-01T00:00:0086.00%
2026-02-01T00:00:0083.58%
2026-03-01T00:00:0082.64%
2026-04-01T00:00:0081.70%
2026-05-01T00:00:0081.46%
2026-06-01T00:00:0081.17%
2026-07-01T00:00:0081.13%
2026-08-01T00:00:0081.82%
-2.20%

BLI - Brand Loyalty Index

The Brand Loyalty Index (BLI) indicates the degree of Listonic app users attachment to individual brands. It shows what percentage of products in category Painkillers and anti-inflammatory drugs added to the Listonic shopping list are entered with the brand.
Show data up to:
Range:
Bezwzględna liczba dodań produktów z kategorii Painkillers and anti-inflammatory drugs (miesięcznie)
MiesiącDodania z markąWszystkie dodania z kategorii
2024-09-01T00:00:0071458505
2024-10-01T00:00:0066718079
2024-11-01T00:00:0066007799
2024-12-01T00:00:00858410107
2025-01-01T00:00:0086549910
2025-02-01T00:00:0076928872
2025-03-01T00:00:0069138275
2025-04-01T00:00:0065577758
2025-05-01T00:00:0062927663
2025-06-01T00:00:0066188014
2025-07-01T00:00:0068698515
2025-08-01T00:00:0069178478
2025-09-01T00:00:0065668178
2025-10-01T00:00:0062907471
2025-11-01T00:00:0058996794
2025-12-01T00:00:0080988557
2026-01-01T00:00:0084009767
2026-02-01T00:00:0071448548
2026-03-01T00:00:0057636974
2026-04-01T00:00:0061977585
2026-05-01T00:00:0056206899
2026-06-01T00:00:001036112765
2026-07-01T00:00:001648520320
2026-08-01T00:00:001582619342

Additions of a product from category Painkillers and anti-inflammatory drugs

Absolute data on adding products from category Painkillers and anti-inflammatory drugs with a brand compared to all additions from the category.
The method of counting additions changed in June 2026 – comparisons with periods before that date may not be fully reliable.
Show data up to:
Range:
Number of additions Painkillers and anti-inflammatory drugs
Number of additions Painkillers and anti-inflammatory drugs with the brand
The data for the analysis comes from shopping lists in Listonic and Moja Gazetka. The study has been supplemented with data from Moja Gazetka since October 2024.From June 2026 the method of counting additions has been refined: re-marking a product as to buy after it was previously checked off as bought (an "uncheck") now also counts as an addition to the list. This change affects data from June 2026 onwards – worth bearing in mind when comparing with earlier periods.
Is your brand missing from the comparison?
rectangles
Want to increase your sales?Contact us
rectangles
Privacy policy
© 2006-2026 Listonic. Listonic dev, Listonic ads and Brand Performance are part of Listonic.
Facebook iconLinkedIn icon